Ethyl 2-(3-((tert-Butoxycarbonyl)amino)bicyclo[1.1.1]pentan-1-yl)acetate, 98%, 10g

Ethyl 1-(2-cyanoethyl)isonipecotate, 95.0%, 1g

2-Bromobutyryl Chloride>98.0%(GC)(T)5g

Benzyl 3-(2-oxoethyl)piperidine-1-carboxylate, 97%, 1g

1,3-Bis(2,6-diisopropylphenyl)-1,3,2-diazaphospholidine 2-Oxide>98.0%(N)1g

(S)-3-Amino-2-hydroxypropanoic acid, 95.0%, 5g

N-Cbz-2-Piperidinecarboxylic acid, 95.0%, 25g

6-Chloronicotinoyl Chloride>98.0%(T)5g

(3-Bromo-2,2-dimethylpropoxy)(tert-butyl)diphenylsilane, 98%, 100mg

N-(2,2,2-trifluoroethyl)-1,4-diazepane-1-sulfonamide hydrochloride, 95.0%, 250mg

1,2,3,3,8-Pentamethyl-5-(trifluoromethyl)-2,3-dihydro-1H-pyrrolo[3,2-g]quinolin-7(8H)-one>98.0%(HPLC)(T)200mg

Single-channel microliter pipette Pipetman® L, 2 to 20 µl, P20L, 1 piece

ETHYL 4-CYANO-3-(2-ETHOXY-2-OXOETHYL)TETRAHYDRO-2H-PYRAN-4-CARBOXYLATE, 95.0%, 1g